Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
80297 studies found for:    pharmacology
Show Display Options
Rank Status Study
21 Completed Single-Dose Clinical Pharmacology Study in Asthmatic Adolescent and Adult Patients
Condition: Asthma
Interventions: Drug: Test treatments CHF 1535 100/6 pMDI (Foster®) TEST1;   Drug: CHF 1535 100/6 pMDI (Foster®) using AeroChamber Plus™ (TEST 2).;   Drug: BDP pMDI 100 µg (Qvar®) plus formoterol fumarate pMDI 6 µg (Atimos®) (REF);   Drug: CHF 1535 100/6 pMDI  (Foster®) (CTR)
22 Completed Clinical Pharmacology Study of MRA in Patient With Rheumatoid Arthritis (RA) With Renal Impairment
Condition: Rheumatoid Arthritis
Intervention: Drug: MRA(Tocilizumab)
23 Completed A Study to Evaluate the Effects of Pharmacological Chaperones in Cells From Patients With Pompe Disease
Conditions: Pompe Disease;   Glycogen Storage Disease Type II
Intervention: Other: Observation
24 Completed A Clinical Pharmacology Study of Saxagliptin in Patients With Type 2 Diabetes Mellitus
Condition: Diabetes
Intervention: Drug: saxaglipitin
25 Recruiting Pharmacological Management of Delirium
Conditions: Delirium;   Cognitive Impairment
Interventions: Behavioral: Reduced exposure to anticholinergics;   Procedure: Reduced exposure to benzodiazepines;   Drug: Haloperidol;   Procedure: Usual care
26 Completed
Has Results
Study on the Anti-tumor Activity, Safety and Pharmacology of IPH2101 in Patients With Smoldering Multiple Myeloma
Condition: Smoldering Multiple Myeloma
Intervention: Drug: IPH2101
27 Completed
Has Results
Combined Behavioral and Pharmacological Intervention for Cardiovascular Risk Reduction in Diabetic Patients
Conditions: Diabetes;   Hypertension;   Dyslipidemia;   Coronary Arteriosclerosis
Interventions: Behavioral: Behavioral counseling and peer support;   Behavioral: Interactive Education;   Behavioral: Role modeling;   Procedure: Pharmacologic case management
28 Completed Pharmacologic Study of Oseltamivir in Healthy Volunteers
Condition: Avian Influenza A Virus
Interventions: Drug: oseltamivir;   Drug: probenecid
29 Completed Pharmacological Interaction Between Clonidine and Methylenedioxymethamphetamine (MDMA)
Conditions: Mood Disorder;   Substance-Related Disorders;   Amphetamine-Related Disorders
Interventions: Drug: 3,4-Methylenedioxymethamphetamine;   Drug: Clonidine;   Drug: placebo
30 Completed Assessment of Cholinergic and Cognitive Function Using Pharmacologic ASL-Perfusion MRI
Condition: Cholinergic Function
Interventions: Drug: Scopolamine;   Drug: Placebo;   Drug: Donepezil
31 Recruiting Pharmacologic Optimization of Voriconazole
Conditions: Invasive Fungal Infection;   Hematological Malignancy
Interventions: Drug: voriconazole;   Drug: voriconazole (dosing according to the SPC)
32 Completed Effect of Sarpogrelate on Platelet Aggregation in Patients With Cerebral Infarction: Dose-Responsive Clinical Pharmacology Study
Condition: Cerebral Infarction
Intervention: Drug: MCI-9042
33 Active, not recruiting
Has Results
Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia
Conditions: Adult Acute Lymphoblastic Leukemia;   Childhood Acute Lymphoblastic Leukemia
Interventions: Other: laboratory biomarker analysis;   Other: pharmacological study;   Drug: asparaginase
34 Recruiting Cyclosporine in Interstitial Cystitis: Efficacy, Safety and Mechanism of Action
Condition: Interstitial Cystitis
Intervention: Drug: Cyclosporine
35 Completed
Has Results
Mode of Action Study of Omalizumab in Patients With Chronic Idiopathic Urticaria (CIU) Who Fail to Respond to Antihistamine Treatment
Condition: Chronic Idiopathic Urticaria
Interventions: Drug: IGE025;   Drug: placebo
36 Active, not recruiting Mechanism of Action Study for Psoriasis
Condition: Psoriasis
Interventions: Drug: Methotrexate;   Drug: Adalimumab (Humira)
37 Completed Safety and Pharmacologic Study of VTX-2337 in Patients With Advanced Cancer
Conditions: Advanced Solid Tumors;   Lymphoma
Intervention: Drug: VTX-2337
38 Terminated Mechanism of Action of Galiximab in Subjects With Previously Untreated Follicular Non-Hodgkin's Lymphoma
Condition: Lymphoma, Non-Hodgkin's
Intervention: Drug: Galiximab
39 Completed Efficacy and Safety of Two Pharmacologic Strategies on Neurocognitive Impairment in HIV Infection. The TRIANT-TE Study
Conditions: Neurocognitive Disturbance;   HIV Infection
Interventions: Drug: Lithium;   Drug: Rivastigmine
40 Completed Pharmacologic Impact on Sedation Assessments
Condition: Pediatric Acute Lung Injury
Intervention: Other: Pharmacokinetic Sampling and pharmacogenetic analysis

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years